Telo Genomics Corp (TSE:TELO)
TSXV:TELO

Telo Genomics Corp (TELO) Stock Price & Analysis

13 Followers

TELO Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.21 - C$0.45
Previous CloseC$0.28
Volume19.00K
Average Volume (3M)27.03K
Market Cap
C$17.35M
Enterprise ValueC$16.66M
Total Cash (Recent Filing)C$727.58K
Total Debt (Recent Filing)C$40.00K
Price to Earnings (P/E)-6.4
Beta1.26
Oct 25, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding59,824,433
10 Day Avg. Volume25,218
30 Day Avg. Volume27,030
Standard Deviation0.31
R-Squared0.08
Alpha0.00537
Financial Highlights & Ratios
Price to Book (P/B)21.70
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

TELO FAQ

What was Telo Genomics Corp’s price range in the past 12 months?
Telo Genomics Corp lowest stock price was C$0.20 and its highest was C$0.45 in the past 12 months.
    What is Telo Genomics Corp’s market cap?
    Currently, no data Available
    When is Telo Genomics Corp’s upcoming earnings report date?
    Telo Genomics Corp’s upcoming earnings report date is Oct 25, 2023 which is in 146 days.
      How were Telo Genomics Corp’s earnings last quarter?
      Telo Genomics Corp released its earnings results on May 18, 2023. The company reported -C$0.012 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.012.
        Is Telo Genomics Corp overvalued?
        According to Wall Street analysts Telo Genomics Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Telo Genomics Corp pay dividends?
          Telo Genomics Corp does not currently pay dividends.
          What is Telo Genomics Corp’s EPS estimate?
          Telo Genomics Corp’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Telo Genomics Corp have?
          Telo Genomics Corp has 59,824,432 shares outstanding.
            What happened to Telo Genomics Corp’s price movement after its last earnings report?
            Telo Genomics Corp reported an EPS of -C$0.012 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.667%.
              Which hedge fund is a major shareholder of Telo Genomics Corp?
              Currently, no hedge funds are holding shares in TSE:TELO

              ---

              Telo Genomics Corp Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
              Learn more about TipRanks Smart Score

              Company Description

              Telo Genomics Corp

              Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.

              ---

              Forecast EPS vs Actual EPS


              Similar Stocks
              Company
              Price & Change
              Follow
              Converge Technology Solutions Corp
              Nymox Pharmaceutical

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis